Papers
10
Total Citations
362
H-Index
7
About
Chi Wei Mok is a pioneering breast surgical oncologist whose work has significantly advanced the field of minimal access breast surgery, with a particular focus on robotic and endoscopic mastectomy techniques. Based in Singapore, Mok has been instrumental in establishing the safety, feasibility, and clinical value of robotic nipple-sparing mastectomy (R-NSM), contributing to landmark consensus statements from the International Endoscopic and Robotic Breast Surgery Symposium in both 2019 and 2025, which together have garnered over 90 citations. His rigorous case-control studies comparing robotic, endoscopic, and conventional nipple-sparing mastectomy approaches — collectively cited more than 200 times — have provided critical evidence on clinical outcomes, patient-reported cosmetic satisfaction, learning curves, and medical costs. Mok led Singapore's first prospective safety trial of robotic mastectomy (PRoMiSing I), helping to establish the technique's regional footprint in Southeast Asia. His research into nipple and skin sensation preservation across 460 cases further demonstrates his commitment to patient-centered outcomes. Through his contributions, Mok has helped redefine modern breast cancer surgery, championing approaches that balance oncological safety with superior aesthetic results.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Evolution of minimal access breast surgery38 citations · 2019
- 6Consensus Statement on Robotic Nipple Sparing Mastectomy Expert Panel13 citations · 2025
- 7
- 8
- 9
- 10Robotic nipple-sparing mastectomy6 citations · 2019